ENSURING ACCESS TO TREATMENT AND RESOURCES FOR PATIENTS IN UNDESERVED COMMUNITIES AFTER SURGERY
A radical prostatectomy is the gold standard for treatment of localized prostate cancer. Although an effective treatment, sexual dysfunction and urinary incontinence are common side effects that can be very stressful for patients undergoing this surgery. PDE5 inhibitors, a type of medication that can help improve sexual dysfunction, and absorbent pads, which can help control a patient’s urinary incontinence during the day, are common treatments to help patients cope with these side effects. These treatments are readily available to most patients, but for patients in underserved communities with poor access to care, they can be costly. The goal of this study is to provide these resources and investigate if patients residing in underserved communities will benefit from receiving these resources.
With help by the Albert Einstein Society (AES) and Einstein Healthcare Network.
Primary Investigator: Eric M. Ghiraldi, DO
Mentor: Serge Ginzburg, MD, FACS
Einstein Medical Center Philadelphia